A June inspection now has the FDA hitting Dr. Reddy’s with a Form 483, with seven observations spotted at its Indian biologics plant in Hyderabad during a site visit that wrapped up this week. The ...
The U.S. Food and Drug Administration (USFDA) has issued seven observations to the biologics manufacturing facility of Dr. Reddy’s Laboratories in Bachupally, Hyderabad. “A Form 483 with the seven ...
Dr Reddys received seven observations from USFDA after June 16-25 Bachupally plant inspection The inspection was a Pre-License Inspection at Bachupally biologics manufacturing facility Earlier, USFDA ...
Dr Reddy's Laboratories announced that US Food and Drug Administration (USFDA) completed a Pre-License Inspection (PLI) at its biologics manufacturing facility in Bachupally, Hyderabad, conducted ...
The Hyderabad-based drug major, Dr Reddy’s Laboratories Ltd, on Thursday (June 25) said the United States Food & Drug Administration (USFDA) has completed a Pre-License Inspection (PLI) at its ...
NEW DELHI: India all-rounder Nitish Kumar Reddy has been ruled out of the two-match T20I series against Ireland starting June 26 in Belfast, and the five T20Is against England which follow. It is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results